Accounts Receivable
Labcorp Holdings Accounts Receivable increased by 8.8% to $2.29B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.8%, from $2.12B to $2.29B. Over 5 years (FY 2020 to FY 2025), Accounts Receivable shows a downward trend with a -3.2% CAGR.
Analysis
How to read this metric
Rapid growth relative to sales may indicate collection issues or aggressive revenue recognition; stability suggests efficient cash conversion.
Detailed definition
This represents the total amount owed to the company by customers for goods or services delivered, minus the allowance f...
Peer comparison
Standard metric for all companies with B2B or credit-based sales models.
accounts_receivable_netHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.21B | $2.34B | $2.26B | $2.24B | $2.22B | $2.16B | $1.79B | $2.34B | $1.90B | $1.96B | $1.91B | $2.08B | $2.09B | $2.06B | $1.94B | $2.12B | $2.12B | $2.11B | $2.10B | $2.29B |
| QoQ Change | — | +5.7% | -3.2% | -1.0% | -1.0% | -2.4% | -17.5% | +31.3% | -18.8% | +2.7% | -2.2% | +8.9% | +0.2% | -1.5% | -5.6% | +9.2% | -0.1% | -0.5% | -0.3% | +8.8% |
| YoY Change | — | — | — | — | +0.3% | -7.3% | -21.0% | +4.7% | -14.1% | -9.6% | +7.2% | -11.1% | +9.7% | +5.2% | +1.6% | +1.9% | +1.5% | +2.5% | +8.2% | +7.8% |
Business Segments
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Diagnostics | $1.33B | $1.32B | $1.26B | $1.40B | $1.41B | $1.40B | $1.35B | $1.51B |
| Biopharma Laboratory Services | — | — | $729.50M | $758.60M | $750.10M | $747.00M | $791.20M | $808.40M |
| Drug Development | $791.60M | $773.70M | — | — | — | — | — | — |
| Total | $2.09B | $2.06B | $1.94B | $2.12B | $2.12B | $2.11B | $2.10B | $2.29B |
Drug Development was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
Accounts Receivable at Other Companies
Frequently Asked Questions
- What is Labcorp Holdings's accounts receivable?
- Labcorp Holdings (LH) reported accounts receivable of $2.29B in Q1 2026.
- How has Labcorp Holdings's accounts receivable changed year-over-year?
- Labcorp Holdings's accounts receivable increased by 7.8% year-over-year, from $2.12B to $2.29B.
- What is the long-term trend for Labcorp Holdings's accounts receivable?
- Over 5 years (2020 to 2025), Labcorp Holdings's accounts receivable has grown at a -3.2% compound annual growth rate (CAGR), from $2.48B to $2.10B.
- What does accounts receivable mean?
- The net amount of money owed by customers after accounting for potential non-payments.